REG - One Health Group PLC - Admission to trading on AIM and first day dealings

One HealthAnnouncement

20/03/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250320:nRST3547Ba&default-theme=true

RNS Number : 3547B  One Health Group PLC  20 March 2025

THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION,
DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR
INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF
SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR
DISTRIBUTION WOULD BE UNLAWFUL.

FOR IMMEDIATE RELEASE

20 March 2025

One Health Group plc

("One Health" or the "Company")

Admission to trading on AIM and first day of dealings

One Health Group plc (AIM: OHGR), a provider of NHS-funded medical procedures,
is pleased to announce the admission of its entire issued share capital being
13,709,615 ordinary shares of 0.5 pence each ("Ordinary Shares") to trading on
AIM, a market operated by the London Stock Exchange ("Admission").

In conjunction with Admission, the Company has completed a successful capital
raising of approximately  £7.8 million (before expenses) through a placing
of new and existing Ordinary Shares with certain institutional and other
investors, a retail offer and an open offer at a price of 180 pence per
Ordinary Share (the "Capital Raising"). The net proceeds from the Capital
Raising will be used primarily to fund (alongside existing cash) the Company's
first owned surgical hub through to operation. The surgical hub is expected to
be operational within one year of construction starting and deliver between
£6 million to £9 million of revenue per annum and is anticipated to be
earnings enhancing in its first full year of operation.

Admission will take place and dealings in the Ordinary Shares will commence at
8:00 a.m. today under the TDIM: 'OHGR' and ISIN GB00BNNT0595. Cancellation of
the Company's Ordinary Shares on the Apex Segment of the AQSE Growth Market
will take place simultaneously with Admission.

Further information in relation to Admission can be found in the Company's
announcement from 19 February 2025. An appendix to the Schedule One, as well
as information required pursuant to AIM Rule 26, is available on the Company's
website at https://www.onehealth.co.uk/investors
(https://www.onehealth.co.uk/investors)

Adam Binns, Chief Executive Officer of One Health, commented: "I am delighted
to announce One Health's admission to AIM. This is a pivotal step in advancing
our mission to provide NHS-aligned healthcare through patient choice and our
scalable surgical hubs and patient centric service. This milestone, bolstered
by a successful capital raising and strong institutional investor confidence,
will enable strategic expansion while maintaining our commitment to reducing
patient waiting times and delivering clinical excellence with sustainable
growth. I extend my gratitude to our team, advisers, and shareholders for
their support as we commence our next chapter supported by our listing on AIM.
I am excited about the prospects for the business, particularly our inaugural
surgical hub,  which will integrate operational excellence and technological
innovation to benefit NHS patients and the broader healthcare system."

Terms used but not defined in this announcement have the same meaning as set
out in the Company's announcement released at 7:00 a.m. on 19 February 2025.
For more information, please contact:

 

 One Health Group plc                                                        via Square1 Consulting

 Derek Bickerstaff, Chairman

 Adam Binns, CEO

 Panmure Liberum (Corporate Adviser, Nominated Adviser and Sole Bookrunner)  Tel: +44 (0) 20 3100 2000

 Emma Earl, Will Goode, Mark Rogers, Joshua Borlant

 Rupert Dearden

 Square1 Consulting                                                          Tel: +44 207 929 5599

 David Bick                                                                  +44 7831 381201

About One Health Group plc

One Health engages over 70 NHS Consultants (excluding anaesthetists) who
sub-specialise in the various surgeries offered by the Company, through a
growing network of community-based outreach clinics and surgical operating
locations. One Health continues to deliver strong growth and in the year to
March 2024 provided much needed care to 13,266 new patients, through almost
34,000 consultations and over 6,000 surgical procedures. One Health deploys
surgeons and anaesthetists that are mostly employed by the NHS, on a
subcontracted basis. It currently works with over 100 professionals across 9
independent hospitals and 37 outreach clinics. Within these community-based
outreach clinics all consultations and post operative physiotherapy is
delivered where required, reducing patient inconvenience and excess travel.

One Health's activities are focused on areas where NHS patient needs are
under-supplied by the local NHS service, population density is relatively high
and the level of private medical insurance or the ability to self-fund is
relatively low. One Health has also sought to expand geographically from its
Head Office in Sheffield into neighbouring counties which meet these criteria.
Currently, the Company's activities are focused in Yorkshire, Lincolnshire,
Derbyshire, Nottinghamshire and Leicestershire. Revenue of over £23 million
in the year to 31 March 2024 was derived from over 60 NHS commissioning bodies
in addition to contracts with local NHS Hospital Trusts to transfer their
internal waiting list patients to One Health for quicker treatment.

One Health's business model has focused to date on four main areas:
orthopaedics, spine, general surgery and gynaecology. The split of inpatient
procedures in the year to 31 March 2024 was as follows: orthopaedics 46% spine
22% general surgery 22% gynaecology 10%.

Spine and orthopaedics are particularly attractive areas for One Health as the
Directors believe that they benefit from powerful growth drivers in terms of
an ageing demographic, physical inactivity and an increasing proportion of the
population being categorised as obese. Within orthopaedics, the most common
surgeries performed by One Health are knee and hip replacements.

Further information on the Company can be found on its website at
www.onehealth.co.uk (http://www.onehealth.co.uk) .

 

The Company's LEI is 984500DC689F5BAD8732.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXJLMFTMTBBBMA